Stonepine Capital Management, LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:01 am Sale |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
Stonepine Capital Management, LLC | 0 0.000% |
-1,304,947 (Position Closed) |
Filing |
| 2023-02-13 10:57 am Purchase |
2022-12-31 | 13G | UroGen Pharma Ltd. URGN |
Stonepine Capital Management, LLC | 1,304,947 5.700% |
108,039 (+9.03%) |
Filing |
| 2022-12-02 11:15 am Purchase |
2022-11-22 | 13G | UroGen Pharma Ltd. URGN |
Stonepine Capital Management, LLC | 1,196,908 5.200% |
1,196,908 (New Position) |
Filing |